NCT01189201 - Rel. BA of Empagliflozin (BI 10773)/Linagliptin FDC Tbl, Comparison With Mono-components, With a Second FDC Tablet and Influence of Food | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 31, 2010

Primary Completion Date

November 30, 2010

Conditions

Healthy

Interventions

DRUG

BI 10773/linagliptin

medium single dose of BI 10773/linagliptin FDC (Formulation A1)

DRUG

BI 10773/linagliptin

medium single dose of BI 10773/linagliptin FDC (Formulation A3)

DRUG

BI 10773/linagliptin SID

medium single dose of mono components BI 10773/linagliptin

DRUG

BI 10773/linagliptin FDC

medium single dose of BI 10773/linagliptin FDC (Formulation A1) after high fat, high caloric meal

Trial Locations (1)

1275.3.1 Boehringer Ingelheim Investigational Site, Biberach